Healthy volunteers test new drug VRG50635 for safety
NCT ID NCT06286475
First seen Dec 16, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This early-phase study tested the safety and how the body absorbs a new drug called VRG50635. It involved 22 healthy adults aged 19 to 55. The goal was to check for side effects and measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lincoln Celerion Inc.,
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.